International Journal of Hypertension / 2012 / Article / Fig 1

Clinical Study

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension

Figure 1

Change from baseline in SBP and DBP by treatment group. (T80/H25, telmisartan 80 mg/hydrochlorothiazide 25 mg: V160/H25, valsartan 160 mg/hydrochlorothiazide 25 mg).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.